Arteris, Inc. (AIP) Stock Price & How to Invest

Last updated November 2026

Short answer

AIP is Arteris, Inc., a semiconductor system IP company that licenses network-on-chip (NoC) interconnect technology used to wire together the blocks inside AI, automotive, and data-center chips. You can buy shares or fractional shares at any major broker, hold it through a small-cap or semiconductor ETF, or treat it as one holding in a thematic AI-infrastructure basket. As of October 16, 2026 the stock closed near $19, up about 22% for the year but about 44% below where it traded three months earlier, after a sharp pullback from a 52-week high near $50.

AIP stock price

As of 2026-11-16, Arteris, Inc. (AIP) last closed at $18.72, up 40.0% over the past year. Over the past 52 weeks it has traded between $12.63 and $48.59.

AIP last close
$18.72
1 day
-3.21%
1 month
-0.21%
1 year
+40.01%
52-week range
$12.63 to $48.59
Last close
2026-11-16

Prices are daily closing prices from Yahoo Finance and may be delayed. For the live quote, check your broker or Arteris, Inc.'s investor relations page. Walnut is informational, not investment advice.

AIP key stats

At $18.72 on November 16, 2026, Arteris, Inc. (AIP) has a market cap of $930M.

Market cap
$930M
P/E (forward)
152.4
Price to book
14.1
Beta
1.97

Market cap, P/E and yield are measured at the $18.72 price on November 16, 2026, from Yahoo Finance figures pulled in November 2026. Earnings date from Yahoo Finance. Walnut is informational, not investment advice.

What's new with Arteris, Inc. (AIP)?

The last two weeks for Arteris, Inc., as of November 17, 2026: the price move, the next earnings date, what the company filed with the SEC, and what analysts changed.

  • AIP closed at $18.72 on November 16, 2026, down 2.5% over the past five trading days (from $19.20).
  • On November 5, 2026, Arteris, Inc. filed its quarterly report (10-Q) with the SEC. Read the 10-Q on sec.gov
  • On November 5, 2026, Arteris, Inc. filed an 8-K with the SEC reporting quarterly results (Item 2.02). Read the 8-K on sec.gov
  • On November 7, 2026, Jefferies lowered its target to $40.00 from $50.00 (Buy).

Prices are daily closes from Yahoo Finance. Filings are read from SEC EDGAR every six hours. Analyst actions come from Yahoo Finance as of November 2026. Walnut is informational, not investment advice.

Arteris, Inc. (AIP) latest quarter

Arteris reported revenue of $25.8 million for Q3 2026, up 48% from a year earlier (Arteris, Nov 5, 2026).

Revenue
$25.8 million
up 48% from a year earlier
Diluted EPS (GAAP)
-$0.23
n/a
Licensing, support and maintenance
$22.4 million
up 41% from a year earlier

Source: Arteris Q3 2026 results, Nov 5, 2026. Full earnings breakdown

What does Arteris, Inc. (AIP) do?

Arteris sells the plumbing that connects the pieces of a modern chip. Its network-on-chip (NoC) interconnect IP, sold under names like FlexNoC, Ncore, and the newer FlexGen, sits between the CPU, GPU, memory, and accelerator blocks on a system-on-chip and manages how data moves between them. Chip designers license this IP rather than build it themselves, which saves engineering time on increasingly complex designs. Arteris makes money in two layers: up-front and recurring license fees (tracked as annual contract value, or ACV) plus per-unit royalties that accrue every time a customer ships a chip containing its IP. That royalty stream is why the company reports metrics like combined ACV plus royalties (a record ~$99.5 million exiting Q2 2026, up 44% year over year) and remaining performance obligations (about $135 million, up 36%) alongside GAAP revenue.

Founded in 2003 and headquartered in Campbell, California, Arteris went public on Nasdaq in 2021 under the ticker AIP. Its IP has shipped in more than 4 billion devices, and its customer roster spans large semiconductor and technology names including AMD, NXP, Arm, and AI-chip startup Tenstorrent, plus automotive chipmakers such as Li Auto and SiEngine, across automotive, AI and machine learning, enterprise computing, and consumer markets. The AI and chiplet boom has raised demand for exactly the kind of high-bandwidth on-chip connectivity Arteris specializes in, and the 2025 launch of FlexGen (a smart, more automated NoC generator) plus the acquisition of hardware-security firm Cycuity broadened its footprint; Arm expanded its partnership in 2026 by licensing Arteris hardware-security assurance technology, and in October 2026 Arteris won government funding to expand a hardware supply-chain security assurance program.

The second quarter of 2026 (reported August 6) brought record revenue of about $24.1 million, up 46%, but a wider GAAP net loss of about $14.1 million and a non-GAAP loss of $0.10 per share versus a ~$0.04 consensus. Management raised full-year revenue guidance to $95-98 million. A new CFO, Saurabh Sinha, started September 8, 2026, succeeding the retiring Nick Hawkins. The stock, which had run up sharply, fell to about $19.08 by October 16, 2026, a market value near $940 million; it is still up about 35% over one year.

What's driving Arteris, Inc. (AIP)?

1. AI and chiplet demand tailwind

As chips get more complex and shift toward multi-die chiplet designs, the interconnect fabric Arteris licenses becomes harder to build in-house and more valuable. AI accelerators, automotive processors, and data-center silicon all need high-bandwidth on-chip connectivity. Management says most new designs now include some form of AI compute, customer-confirmed design starts rose 21% over the trailing twelve months, and enterprise computing averaged about 29% of ACV plus royalties over the past four quarters. This structural demand is why the combined contract-plus-royalty metric has been growing around 40-45%.

2. Recurring license plus royalty model

Arteris earns up-front and recurring license fees plus per-unit royalties that accrue for years as customers ship products containing its IP. Trailing-twelve-month variable royalties reached about $8.6 million at the end of Q2 2026, up about 65% year over year. Because royalties compound off a growing installed base already shipped in over 4 billion devices, past design wins can keep paying out well after the initial contract.

3. New products and blue-chip customers

The 2025 launch of FlexGen, its smart NoC generator, reached over 30 production deployments across 10 customers by year end, and the Cycuity acquisition added hardware-security capability that Arm has now licensed. Named users include AMD, NXP, Tenstorrent, Li Auto, SiEngine and Speedata. Each new design win with a large chipmaker seeds a future royalty stream and deepens Arteris' role in customer roadmaps.

4. Path toward profitability

Arteris carries a very high gross margin (around 88%) but still runs operating and net losses as it invests in engineering and sales; the GAAP operating loss widened to about $13.9 million in Q2 2026. Management guides full-year 2026 revenue to $95-98 million, a non-GAAP operating loss of $7-10 million and free cash flow of $5-9 million, and analysts expect a small profit (about $0.12 per share) in 2027. The debate is how quickly the high-margin revenue base grows into the cost structure.

What are the risks to Arteris, Inc. (AIP)?

Arteris is unprofitable on a GAAP basis (a trailing net loss of about $40 million) and still trades at roughly 11 times sales even after the stock fell about 44% in three months, which leaves little room for disappointment; the Q2 2026 non-GAAP loss was wider than analysts expected. Royalty revenue depends on customers actually shipping chips, so it is exposed to the semiconductor cycle and to design cancellations or delays. The customer base is concentrated among a relatively small number of large chipmakers, and it competes with far larger EDA and IP vendors such as Cadence and Synopsys, plus the risk that big customers build interconnect in-house. Ongoing stock-based compensation dilutes shareholders, and the finance function has a new CFO as of September 2026. The share price has swung between about $12 and $50 over the past year. Walnut is not an investment adviser.

What is the Arteris, Inc. (AIP) forecast?

7 analysts publish price targets on AIP, averaging $34.43 as of November 2026, or +83.9% against the $18.72 share price on November 16, 2026. The published targets run from $25.00 to $40.00, a moderate spread, and the ratings split 7 buy, 0 hold, 0 sell. Over the last six months there has been 1 raise and 2 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full AIP forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

Is AIP a buy or a sell?

We give no verdict on Arteris, Inc.. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. AI and chiplet demand tailwind. As chips get more complex and shift toward multi-die chiplet designs, the interconnect fabric Arteris licenses becomes harder to build in-house and more valuable. The most optimistic published target, $40.00, assumes this works close to its best case.

The case against. Arteris is unprofitable on a GAAP basis (a trailing net loss of about $40 million) and still trades at roughly 11 times sales even after the stock fell about 44% in three months, which leaves little room for disappointment; the Q2 2026 non-GAAP loss was wider than analysts expected. The most pessimistic target, $25.00, is roughly what AIP is worth if this bites instead.

Read the full bull and bear case on AIP, including what would have to change to break either one. Walnut is not an investment adviser.

Has Arteris, Inc. (AIP) split its stock?

No. Arteris, Inc. (AIP) has not split its stock in the last 10 years. The statement covers only the window we check, so an older split in the company’s history is possible. It also matters less than it once did: fractional shares mean a high price per share no longer keeps smaller investors out, which removed most of the practical reason to split.

How is Arteris, Inc. (AIP) valued?

Market cap, P/E and dividend yield at today's price are in the AIP key stats above. The business figures below come from Arteris, Inc.'s reported results as of October 2026 and change when it next reports.

  • Revenue (TTM): ~$84.6 million; Q2 2026 ~$24.1 million, up ~46% year over year
  • ACV plus royalties (exiting Q2 2026): ~$99.5 million, up ~44%; RPO ~$135 million
  • Full-year 2026 guidance: Revenue ~$95 to $98 million (raised); ACV plus royalties ~$102 to $106 million; free cash flow ~$5 to $9 million
  • Net income (TTM): ~-$40 million (net loss; Q2 2026 GAAP loss ~$14.1 million)
  • Gross margin: ~88%
  • Cash / debt: ~$122 million / ~$9 million

As of October 2026: Figures are approximate and tied to the asOf date, so verify live numbers before acting. AIP trades on a price-to-sales multiple of about 11 with a negative P/E because it is still unprofitable, so traditional earnings multiples do not apply; the forward P/E of about 150 reflects tiny expected 2027 earnings. The multiple has roughly halved since July as the share price fell, even though guidance rose. Third-quarter results are due November 3, 2026, with guidance of $24-25 million of revenue and consensus near $24.5 million.

What themes does Arteris, Inc. (AIP) fit?

These are the investment theses AIP naturally fits into. Each links to a full theme guide listing every other stock that belongs and the ETFs commonly used as a passive proxy.

Who competes with Arteris, Inc. (AIP)?

Large EDA and IP vendors

Cadence Design Systems and Synopsys are the dominant chip-design-software and IP companies, and both offer their own network-on-chip and system IP (for example, Cadence's Janus NoC). They have far greater scale, broader tool portfolios, and existing relationships with nearly every chipmaker, making them the most direct competitive threat to Arteris' interconnect franchise.

In-house and alternative interconnect approaches

The largest chip designers can build their own on-chip interconnect fabric rather than license it, and general-purpose IP providers such as Arm offer interconnect technology as part of wider portfolios (while also licensing Arteris security technology). This do-it-yourself option caps how much of the market a specialist like Arteris can address, especially among the biggest, best-resourced customers.

Adjacent system-IP and security providers

Arteris also touches SoC-integration software and, via its Cycuity acquisition, hardware security. In these adjacent areas it overlaps with other specialized IP and verification vendors, and competition there influences how much additional revenue Arteris can layer on top of its core NoC business.

What stocks are similar to Arteris, Inc. (AIP)?

Other names that sit close to AIP: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. They are useful if you want to spread one thesis across several tickers.

How to invest in Arteris, Inc. (AIP)

There are three common ways to get AIP exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so AIP sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where AIP fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

The bottom line on Arteris, Inc. (AIP)

Arteris is a small, fast-growing but still unprofitable IP-licensing business riding the AI and chiplet design wave. Its second quarter of 2026 set records and full-year revenue guidance went up, yet the stock has roughly halved from its summer peak, cutting the price-to-sales multiple to about 11x from about 27x in July. The central question is unchanged: whether royalty and contract growth can catch up to the valuation and turn the losses into profit.

More on Arteris, Inc. (AIP)

Whether AIP is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is AIP a buy or a sell?, and where the stock could go from here in the AIP stock forecast.

For income investors, whether AIP pays a dividend and how the payout looks is covered in does AIP pay a dividend? And to weigh AIP against a peer, read the full side-by-side comparisons: AIP vs AAPL and AIP vs ADBE.

Wondering how AIP fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.

Your questions about Arteris, Inc.

Ask Walnut's AI anything about AIP and see how it fits what you own.

FAQ

What company is AIP?

+

AIP is the Nasdaq ticker for Arteris, Inc., a semiconductor system IP company based in Campbell, California. It licenses network-on-chip (NoC) interconnect and related IP that chip designers use to connect the blocks inside a system-on-chip. Its technology has shipped in more than 4 billion devices across AI, automotive, and consumer markets.

Is AIP a good stock to buy right now?

+

That depends on your goals, time horizon, and risk tolerance, and this is not investment advice. The bull case is rapid growth in contracts and royalties driven by AI and chiplet demand, a very high gross margin, raised 2026 guidance, and a valuation that has come down from about 27x sales in July to about 11x in October 2026. The bear case is that the company is still unprofitable, its latest quarterly loss was wider than expected, and the stock has been extremely volatile. Weigh both against your own portfolio.

How does Arteris make money?

+

Arteris earns money in two layers. First, it charges license fees for its network-on-chip and system IP, tracked as annual contract value (ACV). Second, it collects per-unit royalties each time a customer ships a chip containing that IP. The royalty stream compounds over time as more designs reach production, which is why the company reports combined ACV plus royalties (about $99.5 million exiting Q2 2026) alongside revenue.

Does AIP pay a dividend?

+

No. Arteris does not pay a dividend. It is a growth-stage, currently unprofitable company that reinvests in engineering, sales, and acquisitions rather than returning cash to shareholders. Any return from AIP would come from share-price movement rather than income, which matters if you are building a portfolio for current yield.

Why has AIP stock been so volatile?

+

Arteris is a small-cap, unprofitable company whose revenue is tied to the semiconductor design cycle, so its shares tend to swing on earnings, guidance changes, and AI sentiment. Over the past year the stock has ranged from about $12 to about $50; it fell about 44% in the three months to October 16, 2026, even after reporting record second-quarter revenue and raising guidance. High-multiple, small-cap names generally carry more price volatility than large, profitable ones.

Who are Arteris' main competitors?

+

Its most direct competitors are the large chip-design software and IP vendors Cadence Design Systems and Synopsys, both of which offer their own network-on-chip and system IP. Arteris also competes with in-house interconnect development at big chipmakers and with broader IP providers such as Arm. Its specialist focus is both its edge and a limit on the market it can address.

Who are Arteris' customers?

+

Arteris licenses its IP to semiconductor and technology companies across automotive, AI and machine learning, enterprise computing, and consumer markets. Publicly named users include AMD, NXP, Arm, AI-chip startup Tenstorrent, Li Auto, SiEngine and Speedata. Its newer FlexGen product reached over 30 production deployments across 10 customers by the end of 2025, and its IP has shipped in more than 4 billion devices overall.

What are the main risks of investing in AIP?

+

The main risks are that Arteris is not yet profitable and still trades at about 11 times sales, so expectations remain elevated. Royalties depend on customers shipping chips, which ties results to the semiconductor cycle. The customer base is concentrated, competition from much larger vendors like Cadence and Synopsys is intense, and stock-based compensation dilutes shareholders over time.

How did Arteris do in its latest quarter?

+

In the second quarter of 2026 (reported August 6), revenue was a record $24.1 million, up 46% year over year, ACV plus royalties reached $99.5 million (up 44%) and remaining performance obligations rose 36% to $135 million. The net loss widened to $14.1 million ($0.30 per share), and the non-GAAP loss of $0.10 per share was wider than the ~$0.04 analysts expected. Arteris raised full-year revenue guidance to $95-98 million and reports third-quarter results on November 3, 2026.

How has AIP stock performed in 2026?

+

As of October 16, 2026, AIP closed near $19.08, up about 22.5% year to date and about 35% over one year, but down about 44% over three months and about 14% over the past month, well below its 52-week high of about $50. Seven analysts carry an average price target near $39, and Craig-Hallum started coverage in September with a $30 target.

Guides that feature AIP

AIP is one of the names covered in these guides. Each one puts the stock next to its peers so you can see where it fits rather than judging it alone.

Walnut is informational, not investment advice. Financial figures on this page are approximations; always verify current numbers with Arteris, Inc.'s investor relations page or your broker before making investment decisions.